Ebola death toll in DRC at 41 - new drug in use

2018-08-14 19:02
Nurses working with the WHO (World Health Organisation) administer the Ebola vaccine(File, AFP)

Nurses working with the WHO (World Health Organisation) administer the Ebola vaccine(File, AFP)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Forty-one people have died in the latest outbreak of Ebola in Democratic Republic of Congo, health authorities said on Tuesday, adding that doctors were using a novel drug to treat patients.

Out of 57 recorded cases as of Monday, 41 were fatal, the Congolese Health Ministry and UN's World Health Organisation (WHO) said. Fourteen of the deaths had been confirmed by lab tests, the ministry said.

Last Friday, the ministry put the tally at 37 deaths, either confirmed or suspected.

The outbreak is the country's 10th since 1976, when the disease was first identified in the Democratic Republic of Congo (DRC) near the Ebola River, a tributary of the Congo.

Its epicentre is Mangina in the region of Beni, in the strife-torn eastern province of North Kivu.

For the first time since the outbreak was announced on August 1, one fatality was recorded outside of North Kivu -- in the neighbouring province of Ituri, the ministry's directorate for disease control said.

It added that doctors in Beni had started to use a novel treatment called mAb114 to treat patients with Ebola.

The treatment is "the first therapeutic drug against the virus to be used in an active Ebola epidemic in the DRC," it said.

Developed in the United States, the prototype drug is a so-called single monoclonal antibody - a protein that binds on to a specific target of the virus and triggers the body's immune system to destroy the invader.

The antibody was isolated from a survivor of an Ebola outbreak in the western DRC city of Kikwit in 1995, it said.

In May, the US National Institute of Allergy and Infectious Diseases (NIAID) said it was carrying out the first human trials of mAb114 to test it for safety and tolerance.

 Fighting could hamper treatment 

Use of the experimental treatment in the field comes on the heels of deployment of an unlicensed vaccine in an earlier outbreak of Ebola in the DRC this year.

The decision to use the vaccine, called rVSV-ZEBOV, came after trials during a pandemic in West Africa showed it to be safe and effective, the WHO says.

Immunisation with rVSV-ZEBOV was given to front-line health workers to provide them with additional protection -- a tactic that has been repeated in the latest outbreak.

Ebola causes serious illness including vomiting, diarrhoea and in some cases internal and external bleeding. It is often fatal if untreated.

The WHO has expressed concern that the violence in North Kivu - entailing militias who often fight for control of resources, including a notorious Ugandan rebel force called the Allied Democratic Forces (ADF) - could hamper the fight against the new outbreak.

WHO Director General Tedros Adhanom Ghebreyesus, visiting the area, on Sunday called for "free and secure access" for health workers, the agency said in a statement.

The outbreak in North Kivu was declared a week after WHO and the Kinshasa government hailed the end of a flareup in northwestern Equateur province which killed 33 people.

In the worst Ebola epidemic, the disease struck the West African states of Guinea, Liberia and Sierra Leone in 2013-15, killing more than 11 300 people.

* Sign up to News24's top Africa news in your inbox: SUBSCRIBE TO THE HELLO AFRICA NEWSLETTER

FOLLOW News24 Africa on Twitter and Facebook

Read more on:    world health organisation  |  drc  |  central africa  |  ebola  |  health

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
NEXT ON NEWS24X

Inside News24

 
/News
Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.